Cataract surgery patients treated with branded nepafenac topical eye drops reported better objective and subjective outcomes compared with patients treated with generic ketorolac, according to a study.
“This study proves what many clinicians have observed in thousands of patients, that branded nonsteroidal anti-inflammatory drops are gentler to the eye and easier for patients to take consistently than generic alternatives,” study co-author and OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, told Healio.com/OSN.
The prospective controlled open-label study compared
Uncategorized